Strateos
PrivateLast Round
Series B
Jun 8, 2021
Est. Valuation
$200M
Total Funding Raised
$99.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Strateos operates in Healthcare & Life Sciences and is based in Menlo Park, California. Its latest recorded funding round was a Series B round in June 2021.
Strateos is a biotechnology company that offers a robotic cloud lab platform to streamline and enhance drug discovery and synthetic biology research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Platform-as-a-Service, Workflow Automation
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strateos Comparables
Compare Strateos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emerald Cloud Lab | 88% | |
| Arctoris | 82% | |
| Synthace | 73% |
For institutional investors. Book with your work email.
Strateos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2021 | ||||
| Grant | Sep 15, 2019 | ||||
| Corporate Funding | Jun 3, 2019 | ||||
| Grant | Apr 12, 2018 | ||||
| Series A Extension | Nov 17, 2016 | ||||
Series A | Feb 19, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Strateos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Corporate Funding |
| GV | Seed |
| U.S. Department of Health and Human Services | Grant |
| MITS Capital | Series A |
| Thiel Foundation | Grant |
| Ally Bridge Group | Series B |
| ZhenFund | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 346% MoM, reaching 2.4K.
- Apr 21, 2026
Monthly visitors grew 235% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Strateos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Strateos's valuation, stock price, and market status.
Is Strateos a public or private company?
Strateos is a private company.
What is the current stock price of Strateos?
Strateos is a private company, so its shares have no public market price. Caplight tracks Strateos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Strateos worth (valuation)?
Strateos's valuation is estimated at $200.0M based on funding round data.
Can I buy Strateos stock?
Strateos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Strateos's last funding round?
Strateos's most recent funding round was Series B on June 8, 2021.
Who are the main investors in Strateos?
Key investors in Strateos include GV, Lux Capital, IA Ventures, DCVC (Data Collective).
Will Strateos IPO soon?
No public IPO plans have been announced for Strateos.
How can I track Strateos secondary market activity?
Caplight tracks bids, offers, and trades in Strateos's shares on secondary markets.